MedInvent, LLC has announced CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and sold in the United States since 2009. MedInvent is also pleased to announce its first EU distribution contract with Vedise Hospital in Rome, to market the NasoNeb System in Italy, San Marino and Vatican City. Vedise Hospital has marketed ENT products for over 20 years, serving Otolaryngologists in Italy.